134 related articles for article (PubMed ID: 15076173)
1. Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Rodgers A; Chapman N; Woodward M; Liu LS; Colman S; Lee A; Chalmers J; MacMahon S;
J Hypertens; 2004 Mar; 22(3):653-9. PubMed ID: 15076173
[TBL] [Abstract][Full Text] [Related]
2. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
[TBL] [Abstract][Full Text] [Related]
3. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
[TBL] [Abstract][Full Text] [Related]
4. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
[TBL] [Abstract][Full Text] [Related]
5. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.
Ratnasabapathy Y; Lawes CM; Anderson CS
Drugs Aging; 2003; 20(4):241-51. PubMed ID: 12641480
[TBL] [Abstract][Full Text] [Related]
6. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M;
Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329
[TBL] [Abstract][Full Text] [Related]
7. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
[TBL] [Abstract][Full Text] [Related]
8. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
Chalmers J; Neal B; MacMahon S;
J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
[TBL] [Abstract][Full Text] [Related]
9. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk.
Ohkubo T; Chapman N; Neal B; Woodward M; Omae T; Chalmers J;
Am J Respir Crit Care Med; 2004 May; 169(9):1041-5. PubMed ID: 14990394
[TBL] [Abstract][Full Text] [Related]
10. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
Chalmers J; MacMahon S
J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
[TBL] [Abstract][Full Text] [Related]
11. Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
Berthet K; Neal BC; Chalmers JP; MacMahon SW; Bousser MG; Colman SA; Woodward M;
Blood Press; 2004; 13(1):7-13. PubMed ID: 15083634
[TBL] [Abstract][Full Text] [Related]
12. Progress in reducing the burden of stroke.
Chalmers J; Chapman N
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1091-5. PubMed ID: 11903323
[TBL] [Abstract][Full Text] [Related]
13. PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
J Hum Hypertens; 1998 Sep; 12(9):627-9. PubMed ID: 9783492
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Brugts JJ; Ferrari R; Simoons ML
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
[TBL] [Abstract][Full Text] [Related]
15. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
[TBL] [Abstract][Full Text] [Related]
16. [PROGRESS--a trial on blood pressure lowering after stroke and TIA. ACE inhibitors and diuretics reduce the risk of new stroke].
Terént A
Lakartidningen; 2002 May; 99(20):2286-8, 2291. PubMed ID: 12082946
[No Abstract] [Full Text] [Related]
17. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
18. Trials on blood pressure-lowering and secondary stroke prevention.
Chalmers J
Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
[TBL] [Abstract][Full Text] [Related]
19. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
PROGRESS Collaborative Group
Eur Heart J; 2003 Mar; 24(5):475-84. PubMed ID: 12633548
[TBL] [Abstract][Full Text] [Related]
20. ADVANCE: breaking new ground in type 2 diabetes.
Chalmers J; Perkovic V; Joshi R; Patel A
J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]